1. Home
  2. ELUT vs GNTA Comparison

ELUT vs GNTA Comparison

Compare ELUT & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • GNTA
  • Stock Information
  • Founded
  • ELUT 2015
  • GNTA 2014
  • Country
  • ELUT United States
  • GNTA Italy
  • Employees
  • ELUT N/A
  • GNTA N/A
  • Industry
  • ELUT Medical Specialities
  • GNTA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ELUT Health Care
  • GNTA Health Care
  • Exchange
  • ELUT Nasdaq
  • GNTA Nasdaq
  • Market Cap
  • ELUT 71.5M
  • GNTA 81.2M
  • IPO Year
  • ELUT 2020
  • GNTA 2021
  • Fundamental
  • Price
  • ELUT $2.09
  • GNTA N/A
  • Analyst Decision
  • ELUT Strong Buy
  • GNTA Strong Buy
  • Analyst Count
  • ELUT 2
  • GNTA 1
  • Target Price
  • ELUT $8.00
  • GNTA $25.00
  • AVG Volume (30 Days)
  • ELUT 20.7K
  • GNTA 29.4K
  • Earning Date
  • ELUT 08-06-2025
  • GNTA 01-01-0001
  • Dividend Yield
  • ELUT N/A
  • GNTA N/A
  • EPS Growth
  • ELUT N/A
  • GNTA N/A
  • EPS
  • ELUT N/A
  • GNTA N/A
  • Revenue
  • ELUT $23,711,000.00
  • GNTA N/A
  • Revenue This Year
  • ELUT $20.10
  • GNTA N/A
  • Revenue Next Year
  • ELUT $85.89
  • GNTA N/A
  • P/E Ratio
  • ELUT N/A
  • GNTA N/A
  • Revenue Growth
  • ELUT N/A
  • GNTA N/A
  • 52 Week Low
  • ELUT $1.61
  • GNTA $2.74
  • 52 Week High
  • ELUT $5.12
  • GNTA $7.28
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 58.03
  • GNTA 54.55
  • Support Level
  • ELUT $1.95
  • GNTA $2.74
  • Resistance Level
  • ELUT $2.23
  • GNTA $3.94
  • Average True Range (ATR)
  • ELUT 0.17
  • GNTA 0.29
  • MACD
  • ELUT 0.04
  • GNTA 0.08
  • Stochastic Oscillator
  • ELUT 73.58
  • GNTA 88.33

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: